Use antibiotic stewardship to improve antibiotic prescribing in pharyngitis and respiratory issues
Oct. 2024Important Notices
Improving antibiotic prescribing is a priority as antibiotics are still widely overprescribed for conditions where they are not indicated. Beginning or building an antibiotic stewardship program is an effective way to improve health outcomes and reduce costs related to antibiotic resistance. Providers can embrace antibiotic stewardship efforts using these and other best practices:
- Follow HEDIS® quality measures such as Appropriate Testing for Pharyngitis (CWP), Appropriate Treatment for Upper Respiratory Infection (URI), and Avoidance of Antibiotic Treatment for Bronchitis/Bronchiolitis (AAB).
- Adhere to clinical practice guidelines by prescribing antibiotics strictly in accordance with evidence-based national and local clinical practice guidelines, taking care to prescribe per population.
- Close knowledge gaps by reviewing the Centers for Disease Control and Prevention antibiotic stewardship bundles for online training modules and tools and guidance by care setting, audience, and resource type.
Read Provider Partner Update (see page 19) for more tips to help strengthen antibiotic stewardship efforts and improve health outcomes.
HEDIS® The Healthcare Electiveness’ Data and Information Set (HEDIS®) is a registered trademark of NCQA.
Recent Announcements
CME Webinar Series: Introducing Physicians and their teams to Value-Based Health Care
Please join us for a new CME-accredited webinar series on value-based care. This series is designed to introduce practicing physicians and their teams to value-based health care. Over the course of six sessions, we will define the components of value and identify the tools necessary to deliver high-value care for a population.Feb. 2026Education/Webinars
Bridging Smiles and Systems: Collaborative Care for Children with Chronic Conditions
Please join us for a live, CME-accredited and CEU-accredited webinar on May 13 from noon to 1p.m., that will explore the critical connection between oral health and pediatric chronic conditions such as diabetes, asthma, congenital heart disease, and ADHD.Feb. 2026Education/Webinars
February 2026 UPMC for You and UPMC Community HealthChoices formulary update
Pulmicort Flexhaler has a new distributor, Rubicon Holding. National Drug Codes (NDCs) for Pulmicort Flexhaler from Rubicon Holding are not included in the Medicaid Drug Rebate program and are not covered under the Medicaid Prescription Drug Program. Pulmicort Flexhaler NDCs from the previous manufacturer, H2 Pharma, have been discontinued but may be billed/dispensed until supplies are exhausted.Feb. 2026Pharmacy Updates